Four times faster. That's how much quicker the weight comes back after stopping a GLP-1 compared to stopping a normal diet, according to the British Medical Journal this January. And almost nobody is talking about it. This is episode two of the Skinny Pandemic series, and it's the honest version of the GLP-1 conversation. We cover: What these drugs actually do in the bodyWhy up to 40 percent of the weight lost can be muscle, and how that's largely preventableThe paragraph in the WHO's own guideline that the people selling these medications skipWhat the data really shows about stopping, and why the health benefits reverse tooMicrodosing, compounded versions, and the pill era that removes the last barrierWhat the foundation looks like if a GLP-1 is part of your picture The question to sit with: if you had to take it forever to keep the result, would you still want it? And if not, what's your plan for the day you stop? Everything in this episode is sourced. References below. If this episode hit home, I'd love for you to join me inside The Nourished Reset: a free 14-day guided experience to help you break free from nighttime overeating, food noise and the guilt spiral, so you can finally feel calm around food and at home in your body. No restriction, no willpower, just real tools that actually work. [Sign up here →] And if you're ready to go even deeper, Embodied Nourishment is my signature 16-week coaching program to help you lose that stubborn weight, break free from emotional eating and finally feel calm, confident and free around food - for good. [Learn more & apply here →] Everything I referenced in this episode, in the order it came up, so you can read it yourself. Weight regain after stopping The four-times-faster figure. West et al., systematic review and meta-analysis of weight regain after stopping weight-loss medication, The BMJ, 7 January 2026. Nuffield Department of Primary Care Health Sciences, University of Oxford. 37 studies, 9,341 participants. Average regain of 0.4 kg per month, roughly four times faster than after behavioural interventions, with a return to baseline weight in an average of 1.7 years. Cardiometabolic benefits projected to return to baseline even sooner.BMJ Group summary: https://bmjgroup.com/stopping-weight-loss-drugs-linked-to-weight-regain-and-reversal-of-heart-health-markers/Plain-English write-up, Scientific American: https://www.scientificamerican.com/article/what-happens-after-you-quit-weight-loss-drugs-a-new-study-offers-some-clues/Independent expert reaction, Science Media Centre: https://www.sciencemediacentre.org/expert-reaction-to-systematic-review-and-meta-analysis-looking-at-weight-regain-and-cardiometabolic-markers-after-stopping-obesity-drugs/STEP 1 trial extension (semaglutide): participants regained about two-thirds of lost weight within a year of stopping.SURMOUNT-4 randomised withdrawal trial (tirzepatide), JAMA: https://pubmed.ncbi.nlm.nih.gov/38078870/ · summary via the American College of Cardiology: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/12/09/16/51/SURMOUNT-4Cardiometabolic improvements reversing alongside regain, post-hoc analysis of SURMOUNT-4, JAMA Internal Medicine: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2841273How GLP-1s work in the brain Systematic review of eleven fMRI studies on GLP-1 receptor agonists and brain responses to reward-related food cues. Preprint, not yet peer reviewed, and the authors note small samples and varied protocols: https://www.biorxiv.org/content/10.64898/2026.01.31.702984v2.fullOriginal rat study: Turton et al., Nature 379:69-72, 1996. GLP-1 injected directly into the brain, effect short-lived.Accessible explainer on food noise and the brain, Scientific American: https://www.scientificamerican.com/article/ozempic-quiets-food-noise-in-the-brain-but-how/Muscle and movement Lean mass accounting for roughly 25 to 40 percent of weight lost, peer-reviewed research review: https://www.sciencedirect.com/science/article/pii/S1043661825003524 (note: this proportion is comparable to what's seen after bariatric surgery and large caloric restriction, so the distinguishing factor is the scale of total loss, not the ratio)Physical activity declining after starting a GLP-1 (daily steps 5,047 to 4,487; moderate-to-vigorous activity 28 to 22 minutes; 753 people with wearable data, ~79% female, mean age 52.7). Presented at ENDO 2026, the Endocrine Society annual meeting: https://www.endocrine.org/news-and-advocacy/news-room/2026/maharjan-press-release-endo-2026Muscle preservation with protein and resistance training guidance: six-month prospective cohort of 200 adults presented at the European Congress on Obesity, 2025. Cohort study, not randomised.Protein target above 1.2 g/kg/day spread across meals plus structured resistance training: consensus recommendations, not from the ECO cohort.Guidelines and who these drugs genuinely help WHO guideline on GLP-1 therapies for obesity in adults, December 2025, including the statement that they are not a standalone treatment: https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesityUsage, cost and access KFF Health Tracking Poll (November 2025): 1 in 8 adults currently taking a GLP-1, 1 in 5 ever, half saying they are difficult to afford, 4 in 10 adults with diabetes and 1 in 4 with heart disease having taken one: https://www.kff.org/health-costs/poll-1-in-8-adults-say-theyve-taken-a-glp-1-drug-including-4-in-10-of-those-with-diabetes-and-1-in-4-of-those-with-heart-disease/Microdosing: evidence and the American Association of Clinical Endocrinology position: https://health.usnews.com/best-diet/medication/articles/glp-1-microdosingOrforglipron (Foundayo) FDA approval, 1 April 2026. Daily oral GLP-1, no food or water restrictions, self-pay from $149/month, as little as $25/month with eligible commercial insurance, $50/month for eligible Medicare Part D from 1 July 2026: https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill · coverage: https://www.statnews.com/2026/04/01/eli-lilly-obesity-pill-approved-orforglipron-foundayo/2026 trends, including the Wegovy pill: https://wIf this episode hit home, I'd love for you to join me inside The Nourished Reset: a free 14-day guided experience to help you break free from nighttime overeating, food noise and the guilt spiral, so you can finally feel calm around food and at home in your body. No restriction, no willpower, just real tools that actually work. [Sign up here →] And if you're ready to go even deeper, Embodied Nourishment is my signature 16-week coaching program to help you lose that stubborn weight, break free from emotional eating and finally feel calm, confident and free around food - for good. [Learn more & apply here →] If you enjoyed this episode and feel motivated to finally become the best version of yourself, share your thoughts with me on insta and tag me in your stories so I can see and share! 🥰 Connect with me on Instagram here Get my FREE Notion Journaling Template including 21 Days of Emotional Eating Journaling Prompts